Therapeutic potential of Hedgehog signaling inhibitors in cancer: rationale and clinical data

التفاصيل البيبلوغرافية
العنوان: Therapeutic potential of Hedgehog signaling inhibitors in cancer: rationale and clinical data
المؤلفون: Blake T. Aftab, Charles M. Rudin
المصدر: Clinical Investigation. 2:371-385
بيانات النشر: OMICS Publishing Group, 2012.
سنة النشر: 2012
مصطلحات موضوعية: Cyclopamine, business.industry, Cancer, General Medicine, Pharmacology, medicine.disease, Hedgehog signaling pathway, chemistry.chemical_compound, chemistry, Cancer stem cell, Cancer cell, medicine, Cancer research, Basal cell carcinoma, Clinical efficacy, business, Hedgehog
الوصف: The Hedgehog (Hh)-signaling pathway has become recognized as a key therapeutic target in cancer. In addition to a recently approved first-in-class Hh-pathway inhibitor, several other small-molecule Hh inhibitors are currently under clinical investigation in a variety of cancer settings. Hh signaling occurs through both ligand-dependent and -independent signaling mechanisms and has been implicated in tumor propagation, maintenance of cancer cell stem niches, differentiation, metastatic potential and tumor-microenvironment interactions. Hh-pathway inhibitors have shown robust clinical efficacy in diseases driven by ligand-independent pathway activation. However, use of Hh antagonists in this setting may result in acquired drug-resistance. This reality poses interesting challenges for treating drug-resistant neoplasia. The rationales for therapeutic application of Hh-targeting agents beyond ligand-independent diseases are complex, and the positioning of Hh-targeted agents must consider context-dependent cont...
تدمد: 2041-6806
2041-6792
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ea11d09b91b0cd252e05cd9094324126Test
https://doi.org/10.4155/cli.12.20Test
رقم الانضمام: edsair.doi...........ea11d09b91b0cd252e05cd9094324126
قاعدة البيانات: OpenAIRE